Herpes simplex virus virucidal activity of MST-312 and epigallocatechin gallate. (Q52616911)

4 May 2018

title

Herpes simplex virus virucidal activity of MST-312 and epigallocatechin gallate. (English)

1 reference

4 May 2018

author name string

Prajakta Pradhan

series ordinal

1

1 reference

4 May 2018

Marie L Nguyen

series ordinal

2

1 reference

4 May 2018

publication date

28 March 2018

1 reference

4 May 2018

published in

Virus Research

1 reference

4 May 2018

volume

249

1 reference

4 May 2018

page(s)

93-98

1 reference

4 May 2018

Cell entry mechanisms of HSV: what we have learned in recent years.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Antiviral effect of catechins in green tea on influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Telomerase inhibition as a novel therapy for pediatric ependymoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2018.03.015

10.1016/J.VIRUSRES.2018.03.015

7 January 2021

Identifiers

DOI

1 reference

4 May 2018

PubMed ID

29604359

1 reference

4 May 2018